Bateman, Eric DPrice, DavidWang, Hao-ChienSchonffeldt, PatriciaCatanzariti, Angelinavan der Valk, Ralf J.P.Beekman, Maarten J.H.I.2023-01-192023-01-192022-06-09Bateman, E D, Price, D, Wang, H-C, Schonffeldt, P, Catanzariti, A, van der Valk, R J P & Beekman, M J H I 2022, 'Reply to : Cause or consequence?', European Respiratory Journal, vol. 59, no. 6, 2200103. https://doi.org/10.1183/13993003.00103-20220903-1936https://hdl.handle.net/2164/19859Funding AstraZeneca funded the SABINA III study; was involved in the study design, protocol development, study conduct and statistical analysis; and was given the opportunity to review this manuscript before submission. Publication support was provided by Michelle Rebello, PhD, of Cactus Life Sciences and funded by AstraZeneca.2187879255255engSDG 3 - Good Health and Well-beingasthmaprescriptionshort acting β2-agonistR MedicineRJournal item10.1183/13993003.00103-2022596